NDx Clinical Research, Inc.

Dayton, Ohio 45459

2 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Dementia, Plaque, Amyloid, Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease — Recruiting now
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling